Brain Matters
Blog

ECT, MST, and Other Neuromodulation Therapies to Relieve Severe Psychiatric Illness

Dr. Sarah Lisanby has been deeply involved in developing and improving the safety of life-saving neuromodulatory treatments including electroconvulsive therapy (ECT) and magnetic seizure therapy (MST) for severe psychiatric illness.

Read More
2023 Leading Research Achievements

We are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.

Read More
ADVICE ON MENTAL HEALTH:  Warning Signs & What to Look For: Anxiety and Depression in Childhood

Dr. Jeffrey Borenstein interviews Dr. Joan Luby of Washington University, St. Louis, whose research has changed views on the subject.

Read More
2022 Leading Research Achievements

We are pleased to present you with the 2022 Leading Research Achievements by BBRF Grantees, Prizewinners & Scientific Council Members.

Read More
A RESEARCHER'S PERSPECTIVE: We Are Witnessing a Revolution in Brain Stimulation

Dr. Mark S. George, a pioneer in the field, explains how TMS and related non-invasive brain stimulation technologies are changing the face of psychiatry.

Read More
A Q&A with Dr. Mark S. George on Brain Stimulation for Psychiatric Illness

Dr. George, a pioneer in the field, answers practical questions about TMS and other brain stimulation therapies for psychiatric illness.

Read More
Highly Individualized Deep-Brain Stimulation Helps a Patient With Severe Treatment-Resistant Depression

We write about a novel idea to address brain-based disorders that has moved from theory to bedside in only 3 years. Called closed-loop neuromodulation, it involves using electrical stimulation—delivered via an implanted deep-brain stimulation (DBS) device—at a precise location in the brain. The

Read More
Studying Ketamine’s Rapid Effects to Unlock Secrets for Developing Better Antidepressants

We offer A RESEARCHER’S PERSPECTIVE, based on a presentation given by Lisa M. Monteggia, Ph.D., of Vanderbilt University, at a zoom event hosted by BBRF. The topic of her presentation was “Studying Ketamine’s Rapid Effects to Unlock Secrets for Developing Better Antidepressants

Read More
Accelerating Psychiatric Drug Development

Our PATHWAYS TO THE FUTURE story is about an unconventional approach to developing new psychiatric drugs. Based on an initiative by the National Institute of Mental Health, it’s called “Fast-Fail” and is designed to weed out the weakest drug candidates early in the process, to

Read More
‘An Epidemic of Loneliness and Despair’: How Wisdom Can Help

Q&A with Dilip Jeste, M.D., on the role of wisdom in dealing with what he has called “an epidemic of loneliness and despair” in America.

Read More